Why is Brooks Lab. falling/rising?

As of 24-Sep, Brooks Laboratories Ltd is currently priced at 146.65, reflecting an increase of 0.7, or 0.48%. The stock has shown a trend reversal by gaining after six consecutive days of decline, outperforming its sector by 0.93%. Despite this positive movement today, the stock's delivery volume has significantly decreased by 55.47% compared to the five-day average, indicating falling investor participation. Over the past week, the stock has declined by 4.15%, while it has seen a modest gain of 0.72% over the past month. Year-to-date, the stock is down 20.71%, contrasting with a 4.58% increase in the benchmark index, Sensex.
In the broader market context, the stock's recent performance is notably weaker than the benchmark, particularly in the year-to-date comparison, where it has underperformed significantly. While Brooks Laboratories has outperformed the sector today, the overall trend shows a struggle against the broader market, as indicated by its negative returns over the year and year-to-date. The stock's performance over three and five years has been positive, but the current liquidity suggests that trading activity is not robust, which may contribute to the volatility in its price movements.